切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2007, Vol. 03 ›› Issue (03) : 129 -f3. doi: 10.3877/cma.j.issn.1673-5250.2007.03.103

论著

人血管内皮细胞生长因子受体2小干扰RNA的设计及其表达载体的构建
郭海霞, 薛红漫, 黎阳, 孟哲, 陈环, 李文益   
  1. 中山大学附属第二医院儿科(广州,510120)
  • 出版日期:2007-06-01
  • 基金资助:
    广东省科技计划项目(2006B36301003)

Design of human vascular endothelial growth factor receptor 2 siRNA and construction of its expression vector

Hai-xia GUO, Hong-man XUE, Yang LI, Zhe MENG, Huan CHEN, Wen-yi LI   

  1. The Department of Pediatrics, the Second Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510120, China
  • Published:2007-06-01
引用本文:

郭海霞, 薛红漫, 黎阳, 孟哲, 陈环, 李文益. 人血管内皮细胞生长因子受体2小干扰RNA的设计及其表达载体的构建[J]. 中华妇幼临床医学杂志(电子版), 2007, 03(03): 129-f3.

Hai-xia GUO, Hong-man XUE, Yang LI, Zhe MENG, Huan CHEN, Wen-yi LI. Design of human vascular endothelial growth factor receptor 2 siRNA and construction of its expression vector[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2007, 03(03): 129-f3.

目的

寻找并探讨干扰效果强的人血管内皮细胞生长因子受体2(vascular endothelialgrowth factor receptor 2,VEGFR-2)小干扰RNA (small interference RNA, siRNA),以抑制白血病细胞。

方法

设计人VEGFR-2 siRNA,并转染HL60细胞,MTT法筛选最有效siRNA;合成VEGFR-2shRNA,并构建VEGFR-2 shRNA表达载体;比较VEGFR-2 shRNA表达载体转染HL60细胞后干扰的效果。

结果

筛选出最有效siRNA; VEGFR-2 shRNA正确正向克隆入pENTR TM/U6,成功构建VEGFR-2 shRNA表达载体;以其将VEGFR-2 shRNA瞬时转染入HL60细胞后,细胞生长抑制率为84.9%,P<0.01;VEGFR-2蛋白表达明显减少。

结论

通过必要和有效的筛选机制,才能找到抑制效果相对高的siRNA靶序列;VEGFR-2 shRNA表达载体可在细胞内简单、快速地克隆shRNA,VEGFR-2的表达抑制率高。

Objective

To search and investigate human vascular endothelial growth factor receptor 2 (VEGFR-2) small interference RNA (siRNA) with strong interfering effect to suppress leukemia cell.

Methods

Designed human VEGFR-2 siRNA and screened the most efficient with MTT method after transfecting HL60 cells ; synthesized shRNA and constructed VEGFR-2 shRNA expression vector ; compared the interfering effects after transfecting HL60 cell with VEGFR-2 shRNA expression vector.

Results

The most efficient siRNA was screened ; VEGFR-2 shRNA was cloned correctly into pENTR TM/U6 and constructed VEGFR-2 shRNA expression vector successfully; transfecting HL60 cell transiently with it, cell inhibitory rate was as high as 84. 9%, P<0. 01; expression of VEGFR-2 protein decreased significantly.

Conclusion

SiRNA target sequence with relatively good inhibitory effect should follow necessary and effective screening principals. VEGFR-2 shRNA expression vector can clone shRNA simply and quickly in cells and has high inhibitory rate of VEGFR-2 expression.

图1 VEGFR-2 shRNA表达载体对HL60 VEGFR-2表达影响的Western blot分析
1 Padro T, Ruiz S, Beker K,et al. Increased angiogenesis in the bonemarrow of patient with acute lymphoid leukemia. Blood, 2000,95:2637-2643.
2 Kini AR, Peterson LA, Tallman MS, et al. Angiogenesis in acute promyelocytic leukemia:induction by vascular endothelail growth factor and inhibition by all-trans retincic acid. Blood,2001,97(12):3919-3924.
3 Dias A, Hattori K, Zhu Z,et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest, 2000,106:511-521.
4 Dias S,Hattori K,Heissig B,et al. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce remission of xenotransplanted human leukemia. Proc Natl Acad Sci USA, 2001,98:10857-10862.
5 Shibuya M. Differential roles of vascular endothelial growth factorreceptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol,2006,39:469-478.
6 Zhao G,Peery RB,Yingling JM. Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2tyrosine kinase. Anal Biochem, 2007,360:196-206.
7 Elbashir SM,Martinez J,Patkaniowska A, et al. Functional anatomy of siRNA for mediating efficient RNAi in Drosophila melanogaster embryo lysaate. EMBO J,2001,20: 6877-6888.
8 Lee NS,Dohjima T,Bauer G,et al. Expression of small interfering RNAs targeted against HIV- rev transcripts in human cells. Nat Biotechnol,2002,20:500-505.
9 Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interfere-ence. Nature Biotech, 2004,22:326-330.
10 Amarzguioui M, Prydz H. An algorithm for selection of functional siRNA sequences. Biochem Biophys Res Commun,2004,316:1050-1058.
11 Bernstein E,Caudy AA, Hammond SM, et al. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature,2001,409:363-366.
[1] 曾俐琴, 彭芝兰, 罗喜平. THY1基因影响上皮性卵巢癌SKOV3细胞株生长的体内和体外实验研究[J]. 中华妇幼临床医学杂志(电子版), 2008, 04(03): 216-220.
[2] 顾志波, 郝林, 陆明, 陈建刚. 光动力纳米载体联合si-P3H4治疗膀胱癌的初步探索[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 633-641.
[3] 李公豪, 赵艳丽, 彭中兴, 尹德录, 赵云峰. 下调血管生成素样蛋白7表达对血管紧张素Ⅱ介导的血管平滑肌细胞炎症反应的影响[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(02): 93-99.
阅读次数
全文


摘要